Reduced Intensity Conditioning Treosulfan
MT2025-35 Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning Treosulfan and Fludarabine, With Post-Transplant Cytoxan (PTCy) for the Treatment of Hematological Diseases
Near Add Your Location
Sorting 1 by
MDS Center of Excellence
A Center of Excellence as recognized by the MDS Foundation, is a hospital that has demonstrated its commitment to MDS research. This is accomplished by conducting specialized genetic testing, offering ongoing clinical trials for MDS patients, and actively participating in peer-reviewed MDS research.
University of Minnesota - Masonic Cancer Center
Minneapolis, MN
- Accepting patients
- Show Principal Investigator
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.